Cooper C. Collins - Nov 18, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Director
Signature: /s/ Cooper C. Collins
Stock symbol: TXMD
Transactions as of: Nov 18, 2021
Transactions value $: $578,500
Form type: 4
Date filed: 11/22/2021, 05:30 AM
Previous filing: Aug 19, 2021
Next filing: Aug 22, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Purchase	$579K	+1M	+80.85%	$0.58	2.24M	Nov 18, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.5581 to $0.5850 for an average weighted purchase price of $0.5785. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.5581 to $0.5850 for an average weighted purchase price of $0.5785. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.